Advances in Breast Cancer Detection /
This book gives a synthesis of the latest advances in the early diagnosis of breast cancer. The information on mammographic screening and follow-up trials from Scandinavian and American screening centers is particularly important. The book also discusses cost/benefit problems, radiation risk from sc...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
1990.
|
| Series: | Recent results in cancer research ;
119. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- From the Contents: Relative Doses in Mammography
- Earlier Detection of Breast Cancer: An Overview
- Inflammatory Disease of the Breast
- Stellate Lesions of the Breast
- Screening for Breast Cancer: Opportunities, Status and Challanges
- Follow up Studies of the Health Insurance Plan Study and the Breast Cancer Detection Demonstration Project Screening Trials in the USA
- Low-Cost Mass Screening as a Means of Reducing Overall Mortality from Breast Cancer
- Screening for Breast Cancer with Mammography in Bohuslän County, Sweden
- Evaluation and Comparison of Mammographic Quality at Facilities Participating in a Regional Breast Cancer Awareness Program
- Quality Requirements in Mammographic Screening in Sweden
- One versus Two Views per Breast for Screening Mammography
- Mammographic Features of Malignancy Found during Screening
- Breast Cancer Screening in Iceland: Preliminary Results
- Stereotactic, X-Ray Guided, Fine Needle Aspiration Biopsy of Nonpalpable Breast Lesions: Comparison with the Coordinate Grid Localization Technique
- Stereotactic Breast Puncture: An Indispensable Complement to the Detection of Breast Cancers within the Framework of a Screening Program
- Stereotaxic Fine Needle Aspiration (SFNA) of Nonpalpable Breast Lesions with the Cytoguide Unit: First Experiences
- Preoperative Diagnostic and Prognostic Information on Nonpalpable Breast Tumors.